These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 13437249)
1. Chymotrypsin as a debriding agent. PRUETER RD; STEIN M; DRUM JA; KALZ F Can Med Assoc J; 1957 Jun; 76(12):1040-3. PubMed ID: 13437249 [No Abstract] [Full Text] [Related]
2. Analysis of the effect of a proteolytic enzyme in the treatment of necrotic wounds. LEAGUS CJ; LING CS; STAHLGREN LH Antibiotic Med Clin Ther (New York); 1960 Sep; 7():566-8. PubMed ID: 13759910 [No Abstract] [Full Text] [Related]
3. Use of proteolytic enzymes as debriding agents. HOWES EL Surgery; 1957 Nov; 42(5):948-52. PubMed ID: 13486409 [No Abstract] [Full Text] [Related]
4. Biological assay of proteolytic enzymes capable of debriding third degree burn eschars. WEBSTER ME; CLARK WR; CONKLIN DA; ALTIERI PL; BERMAN S; LOWENTHAL JP; GOCHENOUR RB Proc Soc Exp Biol Med; 1961 May; 107():79-83. PubMed ID: 13783662 [No Abstract] [Full Text] [Related]
5. "Debricin": a new agent for wound debridement. ROB C; SINGER A Br Med J; 1959 Nov; 2(5159):1069-71. PubMed ID: 14437728 [No Abstract] [Full Text] [Related]
6. Action of Chymotrypsin agr and Chymotrypsin B upon Several Protein Substrates. Ambrose JA; Laskowski M Science; 1952 Mar; 115(2987):358-9. PubMed ID: 17748857 [No Abstract] [Full Text] [Related]
7. The cytologic diagnosis of gastric cancer by chymotrypsin lavage. KLAYMAN MI; MASSEY BW; PLETICKA S; GALAMBOS JT; BRANDBORG L; KIRSNER JB; PALMER WL Gastroenterology; 1955 Nov; 29(5):849-53. PubMed ID: 13270813 [No Abstract] [Full Text] [Related]
8. [Splitting of serum albumin with various quantities of chymotrypsin and autolysis of chymotrypsin]. CHERNIKOV MP Biokhimiia; 1955; 20(6):657-64. PubMed ID: 13304105 [No Abstract] [Full Text] [Related]
9. Sutilains ointment as a topical debriding agent in burns. Grossman AR Int Surg; 1973 Feb; 58(2):93-6. PubMed ID: 4631388 [No Abstract] [Full Text] [Related]
10. [The dinitrophenyl derivatives of chymotrypsinogen and of crystalline alpha-chymotrypsin]. DESNUELLE P; ROVERY M; FABRE C C R Hebd Seances Acad Sci; 1951 Dec; 233(23):1496-8. PubMed ID: 14905630 [No Abstract] [Full Text] [Related]
11. Drugs: actions and reactions. Debriding enzymes. Alterescu V; Young C J Enterostomal Ther; 1984; 11(3):122-4. PubMed ID: 6371089 [No Abstract] [Full Text] [Related]
12. The cytologic diagnosis of gastric cancer of chymotrypsin lavage. II. The detection of early malignancy. KLAYMAN MI; MASSEY BW; PLETICKA S; GALAMBOS JT; BRANDBORG L; KIRSNER JB; PALMER WL Gastroenterology; 1955 Nov; 29(5):854-64. PubMed ID: 13270814 [No Abstract] [Full Text] [Related]
14. Further observations on the action of chymotrypsin on insulin. PHILLIPS DM Biochem J; 1951 Sep; 49(4):506-12. PubMed ID: 14886316 [No Abstract] [Full Text] [Related]
15. The nature of the reaction between diisoprophylfluorophosphate and chymotrypsin. OOSTERBAAN RA; KUNST P; COHEN JA Biochim Biophys Acta; 1955 Feb; 16(2):299-300. PubMed ID: 14363273 [No Abstract] [Full Text] [Related]
16. [Degradation of chymotrypsinogen by chymotrypsin]. ROVERY M; POILROUX M; YOSHIDA A; DESNUELLE P Biochim Biophys Acta; 1957 Mar; 23(3):608-20. PubMed ID: 13426173 [No Abstract] [Full Text] [Related]
17. Studies on proteolytic enzymes. I. Toxicology of crystalline trypsin and chymotrypsin. HENDLEY CD; ROBBINS KC; DERTINGER B; CLEMENTS GR; ERCOLI N Arch Int Pharmacodyn Ther; 1956 Apr; 106(1-2):164-77. PubMed ID: 13328223 [No Abstract] [Full Text] [Related]